Ronnie T.P. Poon - Concepedia

Author

Ronnie T.P. Poon

Also Known As

Belghiti, Jacques, Poon, Ronnie, R Poon, R T P Poon, R T Poon, R. Poon, R. T. Poon, R. T.P. Poon, R.T.P. Poon, Ronnie Poon

182

Publications

14.9K

Citations

H-Index

Concepts

All Affiliations

University of Hong Kong Queen Mary Hospital Chinese University of Hong Kong National University of Singapore Kindai University

About

Ronnie T.P. Poon is an author at University of Hong Kong specializing in medicine, hepatocellular carcinoma, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	35	3.8K
2	Health Sciences	9	9	833
3	Engineering	1	1	55
4	Natural Sciences	1	1	25
5	Biochemistry	1	1	25

Ronnie T.P. Poon

Publications

13.8K

Citations

H-Index

Page 1

	Year	Citations
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma Masao Omata, Laurentius A. Lesmana, Ryosuke Tateishi, Hepatology International	2010	1K
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma Wing‐Kin Sung, Hancheng Zheng, Shuyu Li, Nature Genetics HepatologyHepatitisVirologyPathologyLiver Cancer	2012	981
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study Philip J. Johnson, Shukui Qin, Joong‐Won Park, Journal of Clinical Oncology	2013	765
Tumor Size Predicts Vascular Invasion and Histologic Grade Timothy M. Pawlik, Keith A. Delman, Jean‐Nicolas Vauthey, Liver Transplantation	2005	636
Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study Josep M. Llovet, Thomas Decaens, Jean‐Luc Raoul, Journal of Clinical Oncology	2013	592
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib Andrew X. Zhu, Masatoshi Kudo, Eric Assénat, JAMA	2014	564
Yes‐associated protein is an independent prognostic marker in hepatocellular carcinoma Zhi Xu, Tzy‐Jyun Yao, Nikki P.Y. Lee, Cancer	2009	535
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma Zhengyan Kan, Hancheng Zheng, Xiao Liu, Genome Research	2013	525
Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma Oscar W.H. Yeung, Chung Mau Lo, Chang-Chun Ling, Journal of Hepatology OncologyTumour GrowthHepatocellular CarcinomaMedicineLiver Physiology	2014	484
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial Masatoshi Kudo, Guohong Han, Richard S. Finn, Hepatology	2014	342

Page 1